Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1

Interventions

Observation 21 Blood Specimen Collection 20 Drug Therapy 13 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 Immunotherapy 7 Immune Checkpoint Inhibitors 7 Positron Emission Tomography Computed Tomography 5 Hematologic Tests 5 Watchful Waiting 4 Neoadjuvant Therapy 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 darolutamide 3 Tyrosine Kinase Inhibitors 3 Therapeutics 3 Standard of Care 3 Radiotherapy 3 Indocyanine Green 3 Imatinib Mesylate 3 Endoscopic Mucosal Resection 3 Docetaxel 3 Cyclophosphamide 3 Capecitabine 3 Artificial Intelligence 3 tislelizumab 2 pertuzumab 2 palbociclib 2 obinutuzumab 2 nilotinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × Triiodothyronine × Clear all

NCT06647602 2026-02-10

THRIVE

University Medical Center Groningen

Not yet recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡